Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Patent Action
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1177)
•••
Post by Pandoraon May 06, 2021 7:58pm
424 Views
Post# 33149259

Patent Action

Patent Action
Not sure where they go with this now. It says "Final Rejection" but sometimes they still retrieve those and continue on. At this point though it is stalled.


Select New Case Application Data Transaction History Image File Wrapper Continuity Data Published Documents Correspondence Data Assignments Display Download References
Examiner's search strategy and results
Mail Room Date sort by Mail Room Date What is a Document Code Document Code sort by Document Code Document Description sort by Document Description What is a Document Code Document Category sort by Document Category Page Count sort by Page Count Download the selected documents as PDF
04-28-2021 CTFR Final Rejection PROSECUTION 9
04-28-2021 892 List of references cited by examiner PROSECUTION 1
04-28-2021 SRFW Search information including classification, databases and other search related notes PROSECUTION 2
04-28-2021 FWCLM Index of Claims PROSECUTION 1
04-28-2021 SRNT  
This application is officially maintained in electronic form. To View: Click the desired Document Description. To Download and Print: Check the desired document(s) and click Start Download.
Available Documents
 
5/289,574 FIBER OPTIC LIGHT DELIVERY, MONITORING AND APPARATUS THEREFORE T1081/20041 Printer Friendly Version
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities